Vacc-Syn Biotech Private Limited, a dissolved under section 54 private limited company, was established on 09 July 2007 in Thane, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the pharma sector, it holds CIN: U24230MH2007PTC172190. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹4.00 Cr.
It upholds a compliant status. Employing 3 professional, Its leadership includes Sanjay Prabhakar Bawsay (Director), Kamal Kishore Gurnani (Irp/Rp/Liquidator), Madhavi Sanjay Bawsay (Director). It holds ₹40.50 Cr open charges and ₹17.67 Cr settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 127-128, Laxmi Market, 1St Floor, Vartak Nagar,, Thane, Maharashtra, 400606.
U24230MH2007PTC172190
172190
09 July 2007
₹4.00 Cr
₹4.00 Cr
Roc Mumbai
Unlisted
Dissolved Under Section 54
Explore comprehensive insights into Vacc-Syn Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Prabhakar Bawsay | Director | 09 Jul 2007 | Current |
| Kamal Kishore Gurnani | Irp/Rp/Liquidator | 08 Jan 2024 | Current |
| Madhavi Sanjay Bawsay | Director | 09 Jul 2007 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vacc-Syn Biotech Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 26.72% decrease. The company also saw a substantial fall in profitability, with a 97.7% decrease in profit. The company's net worth Soared by an impressive increase of 1555.05%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Vacc-Syn Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹405,000,000.00
₹176,700,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2013 | Bank Of India | ₹40.50 Cr | Open |
| 27 Aug 2010 | Bank Of India | ₹10.00 Cr | Satisfied |
| 23 Jul 2009 | Bank Of India | ₹7.67 Cr | Satisfied |
Explore comprehensive loan charge details -
Vacc-Syn Biotech has a workforce of 3 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Vacc-Syn Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vacc-Syn Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kamal Kishore Gurnani was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 08 Jan 2024 & has been associated with this company since 1 year 10 months . was completed.
Progress on Vacc-Syn Biotech Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.
Vacc-Syn Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was recorded as a recent event.
A charge registered on 27 Aug 2010 via Charge ID 10244807 with Bank Of India was fully satisfied on 01 Jul 2015. was recorded as a recent event.
Progress on A charge registered on 23 Jul 2009 via Charge ID 10173388 with Bank Of India was fully satisfied on 01 Jul 2015. was documented.
Progress on A charge with Bank Of India of Rs. 40.50 Cr registered on 22 Oct 2013 with Charge ID 10459448 was modified on 30 Mar 2015. was documented.
The CIN of Vacc-Syn Biotech Private Limited is U24230MH2007PTC172190.
Vacc-Syn Biotech Private Limited is headquartered at 127-128, Laxmi Market, 1St Floor, Vartak Nagar,, Thane, Maharashtra, 400606.
Vacc-Syn Biotech Private Limited was incorporated on 09 July 2007.
The current directors of Vacc-Syn Biotech Private Limited are
The primary industry of Vacc-Syn Biotech Private Limited is Pharma.
Vacc-Syn Biotech Private Limited is unlisted.
The authorized capital of Vacc-Syn Biotech Private Limited is ₹4.00 Cr, and the paid-up capital is ₹4.00 Cr.
The compliance status of Vacc-Syn Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX